$260 Thousand is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 19 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EOCWU | ELLIOTT OPPORTUNITY II CORP | $20,460 | +1.4% | 2,000,000 | 0.0% | 7.86% | +3.5% | |
| TXN | TEXAS INSTRUMENTS INC | $5,952 | +12.6% | 32,000 | 0.0% | 2.29% | +14.9% | |
| IMTX | IMMATICS NV | $4,812 | -20.8% | 697,431 | 0.0% | 1.85% | -19.1% | |
| VT | VANGUARD TOT WORLD STK ETFetfs | $2,724 | +6.8% | 29,585 | 0.0% | 1.05% | +9.0% | |
| BOND | PIMCO ACTIVE BOND EXCHANGE-T | $1,438 | +2.5% | 15,502 | 0.0% | 0.55% | +4.5% | |
| CDAK | CODIAK BIOSCIENCES INC | $148 | -56.1% | 847,108 | 0.0% | 0.06% | -55.1% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $87 | +27.9% | 35,714 | 0.0% | 0.03% | +26.9% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $71 | -36.0% | 245,678 | 0.0% | 0.03% | -35.7% | |
| TFFP | TFF PHARMACEUTICALS INC | $15 | -34.8% | 22,066 | 0.0% | 0.01% | -33.3% | |
| POR | PORTLAND GENERAL ELECTRIC CO | $6 | 0.0% | 118 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.